The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes
Open accessAbstract
Most tumor cells function poorly as antigen-presenting cells in part because they do not express costimulatory molecules. To provide costimulation to T lymphocytes that recognize tumor cells, we constructed a CD28-like receptor specific for GD2, a ganglioside overexpressed on the surface of neuroblastoma, small-cell lung carcinoma, melanoma, and other human tumors. Recognition of GD2 was provided by a single-chain antibody derived from the GD2-specific monoclonal antibody 3G6. We demonstrate that the chimeric receptor 3G6-CD28 provides CD28 signaling upon specific recognition of the GD2 antigen on tumor cells. Human primary T lymphocytes retrovirally transduced with 3G6-CD28 secrete interleukin 2, survive proapoptotic culture conditions, and selectively undergo clonal expansion in the presence of an antiidiotypic antibody specific for 3G6-CD28. Polyclonal CD8+ lymphocytes expressing 3G6-CD28 are selectively expanded when cultured with cells expressing allogeneic major histocompatibility complex class I together with GD2. Primary T cells given such an antigen-dependent survival advantage should be very useful to augment immune responses against tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
The Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301703 · Cited by 1,043
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
Miller, A. D., Garcia, J. V., von Suhr, N., Lynch, C. M., Wilson, C., & Eiden, M. V. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2220-2224.1991 · Cited by 627
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
Jenkins, M. K., Taylor, P. S., Norton, S. D., & Urdahl, K. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2461 · Cited by 562
Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G., & Nadler, L. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6586 · Cited by 548
Tumor antigens recognized by T cells
Boon, T., Coulie, P. G., & Van den Eynde, B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80020-5 · Cited by 537
Cancer antigens: immune recognition of self and altered self.
Houghton, A. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.1 · Cited by 420
Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.
Rosenberg, S. A. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.180 · Cited by 390
Rivière, I., Brose, K., & Mulligan, R. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6733 · Cited by 364
Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.
Cheung, N. V., Saarinen, U. M., Neely, J. E., et al. (1985) · PubMed · Cited by 322
Self-citationHara, T., Fu, S. M., & Hansen, J. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.6.1513 · Cited by 278
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
CD28 costimulation prevents cell death during primary T cell activation
Noel, P. J., Boise, L. H., Green, J. M., & Thompson, C. B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.636 · Cited by 263
Receptor-stimulated death pathway is opened by antigen in mature T cells.
Russell, J. H., White, C. L., Loh, D. Y., & Meleedy-Rey, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2151 · Cited by 246
Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle
Boehme, S. A., & Lenardo, M. J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230724 · Cited by 239
The ups and downs of T cell costimulation
Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90086-8 · Cited by 235
Activation-induced death of mature T cells in the regulation of immune responses
Russell, J. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80114-6 · Cited by 230
Upstream-Downstream: CD28 Cosignaling Pathways and T Cell Function
Rudd, C. E. (1996) · Immunity · doi:10.1016/s1074-7613(00)80479-3 · Cited by 225
Induction of anti-self-immunity to cure cancer
Nanda, N. K., & Sercarz, E. E. (1995) · Cell · doi:10.1016/0092-8674(95)90047-0 · Cited by 196
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response
Radvanyi, L. G., Shi, Y., Vaziri, H., Sharma, A., Dhala, R., Mills, G. B., & Miller, R. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1788 · Cited by 194
Manipulation of costimulatory signals to enhance antitumor T-cell responses
Allison, J. P., Hurwitz, A. A., & Leach, D. R. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80077-8 · Cited by 171
Gallardo, H. F., Tan, C., Ory, D., & Sadelain, M. (1997) · Blood · doi:10.1182/blood.v90.3.952 · Cited by 170
Self-citationThe Complexities of T‐Cell Co‐stimulation: CD28 and Beyond
Sperling, A. I., & Bluestone, J. A. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00924.x · Cited by 160
Schwartz, R. H., Mueller, D. L., Jenkins, M. K., & Quill, H. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.072 · Cited by 159
Stein, P. H., Fraser, J. D., & Weiss, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3392 · Cited by 150
Boise, L., Noel, P. J., & Thompson, C. B. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80067-0 · Cited by 139
June, C. H., Ledbetter, J. A., Lindsten, T., & Thompson, C. B. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.153 · Cited by 112
Groux, H., Monté, D., Plouvier, B., Capron, A., & Ameisen, J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230734 · Cited by 108
New strategies for enhancing the immunogenicity of tumors
Pardoll, D. M. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90127-e · Cited by 87
Ueda, Y., Levine, B. L., Huang, M. L., Freeman, G. J., Nadler, L. M., June, C. H., & Ward, S. G. (1995) · International Immunology · doi:10.1093/intimm/7.6.957 · Cited by 73
GD2 oligosaccharide: target for cytotoxic T lymphocytes.
Zhao, X. J., & Cheung, N. V. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.67 · Cited by 48
Self-citationBaroja, M. L., Lorré, K., Vaeck, F. V., & Ceuppens, J. L. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90188-3 · Cited by 41
Gene-modified tumor cells as cellular vaccine
Baskar, S. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050318 · Cited by 35
Methods for the Construction of Retroviral Vectors and the Generation of High-Titer Producers
Rivière, L., & Sadelain, M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-484-4:59 · Cited by 31
Self-citationTeng, J. M. C., King, P. D., Sadra, A., Liu, X., Han, A. S., Selvakumar, A., August, A., & Dupont, B. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02643.x · Cited by 23
Cerdan, C., Martin, Y., Courcoul, M., Mawas, C. E., Birg, F., & Olive, D. (1995) · Research in Immunology · doi:10.1016/0923-2494(96)80251-3 · Cited by 14
Beerli, R. R., Bréard, J., Comisso, M., Bohuon, C., Pallardy, M. J., & Bertoglio, J. H. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0045 · Cited by 14
A comparison of three statistical models for IDDM associations with HLA
Graham, J., Kockum, I. S., Breslow, N. E., Lernmark, Å., & Holmberg, E. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02599.x · Cited by 8
Cited by
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
Chimeric Antigen Receptor Therapy
June, C. H., & Sadelain, M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706169 · Cited by 2,331
Self-citationThe Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Self-citationHuman T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
Maher, J., Brentjens, R. J., Gunset, G., Rivière, I., & Sadelain, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-70 · Cited by 1,034
Self-citationTherapeutic T cell engineering
Sadelain, M., Rivière, I., & Riddell, S. (2017) · Nature · doi:10.1038/nature22395 · Cited by 879
Self-citation
Metadata
- Authors
- Krause, A., Guo, H.-F., Latouche, J.-B., Tan, C., Cheung, N.-K. V., & Sadelain, M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-08-17
- Volume
- 188
- Issue
- 4
- Pages
- 619-626
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2005354199
- Cited by
- 365
- References
- 43
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.